Loading…
A commentary argues that the Canada-China canola dispute, which Canada has taken to the WTO, was a potential gain for US biotech but is less valuable now that the Biden administration is blocking the WTO Appellate Body. It says Canada has a strong legal case against China's health and safety restrictions.
The dispute's trade-policy outlook matters for canola flows, but the piece does not directly change current supply or prices.
wita.orgMarc L. Busch, The HillOct 1, 2021Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
